The estimated Net Worth of Alexander R Mackenzie is at least $9.58 Million dollars as of 2 December 2021. Alexander Mackenzie owns over 41,360 units of Pfizer stock worth over $2,588,725 and over the last 8 years he sold PFE stock worth over $6,990,719. In addition, he makes $0 as Executive Vice President and Chief Development Officer at Pfizer.
Sign up
Alexander Mackenzie PFE stock SEC Form 4 insiders trading
Alexander has made over 14 trades of the Pfizer stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 41,360 units of PFE stock worth $2,244,194 on 2 December 2021.
The largest trade he's ever made was exercising 41,615 units of Pfizer stock on 23 February 2019 worth over $875,163. On average, Alexander trades about 14,874 units every 79 days since 2016. As of 2 December 2021 he still owns at least 87,280 units of Pfizer stock.
You can see the complete history of Alexander Mackenzie stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Alexander Mackenzie biography
Dr. Alexander R. Mackenzie serves as Executive Vice President, Chief Development Officer of the Company. Senior Vice President, Chief Development Officer from March 2016 until June 2016. Group Senior Vice President and Head, Pharma Therapeutics Research and Development from 2010 until March 2016. Dr. MacKenzie represents Pfizer as a member of the Board of Directors of ViiV Healthcare Limited, TransCelerate Biopharma Inc. and the National Health Council.
How old is Alexander Mackenzie?
Alexander Mackenzie is 60, he's been the Executive Vice President and Chief Development Officer of Pfizer since 2016. There are 10 older and 19 younger executives at Pfizer. The oldest executive at Pfizer Inc. is Wyllie Don Cornwell, 72, who is the Independent Director.
What's Alexander Mackenzie's mailing address?
Alexander's mailing address filed with the SEC is PFIZER INC.-CORP. SECRETARY, 235 EAST 42ND ST., NEW YORK, NY, 10017.
Insiders trading at Pfizer
Over the last 12 years, insiders at Pfizer have traded over $216,003,942 worth of Pfizer stock and bought 24,324 units worth $872,198 . The most active insiders traders include Shantanu Narayen, Ian C Read, and James M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of $2,169,896. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth $147,714.
What does Pfizer do?
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
What does Pfizer's logo look like?
Complete history of Alexander Mackenzie stock trades at Pfizer
Pfizer executives and stock owners
Pfizer executives and other stock owners filed with the SEC include:
-
Albert Bourla,
Chairman of the Board, Chief Executive Officer -
Frank D'Amelio,
Chief Financial Officer, Executive Vice President - Business Operations and Global Supply -
Mikael Dolsten,
Chief Scientific Officer, President - Worldwide Research, Development and Medical -
John Young,
Chief Business Officer, Group President -
Dr. Albert Bourla D.V.M., DVM, Ph.D.,
Chairman & CEO -
Frank A. D'Amelio,
CFO & Exec. VP -
Dr. Mikael Dolsten M.D., Ph.D.,
Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical -
Angela Hwang,
Group Pres of Biopharmaceuticals Group -
John D. Young,
Advisor -
Shantanu Narayen,
Lead Independent Director -
Wyllie Don Cornwell,
Independent Director -
Helen Hobbs,
Independent Director -
Suzanne Nora Johnson,
Independent Director -
Joseph Echevarria,
Independent Director -
James Kilts,
Independent Director -
Ronald Blaylock,
Independent Director -
Dan Littman,
Independent Director -
Scott Gottlieb,
Independent Director -
James Quincey,
Independent Director -
Susan Hockfield,
Independent Director -
Susan Desmond-Hellmann,
Director -
Gordon Loh,
Senior Vice President, Corporate Audit -
Jennifer Damico,
Senior Vice President, Principal Accounting Officer, Controller -
Sally Susman,
Chief Corporate Affairs Officer, Executive Vice President -
Alexander Mackenzie,
Executive Vice President, Chief Development Officer -
Douglas Lankler,
Executive Vice President, General Counsel -
Rady Johnson,
Chief Compliance, Quality and Risk Officer, Executive Vice President -
Lidia Fonseca,
Executive Vice President, Chief Technology Officer and Digital Officer -
Dawn Rogers,
Chief Human Resource Officer, Executive Vice President -
Angela Hwang,
Group President, Pfizer Biopharmaceuticals Group -
Rady A. Johnson,
Exec. VP and Chief Compliance, Quality & Risk Officer -
Douglas M. Lankler,
Exec. VP & Gen. Counsel -
Christopher J. Stevo CFA,
Sr. VP & Chief Investor Relations Officer -
Lidia L. Fonseca,
Exec. VP and Chief Digital & Technology Officer -
Jennifer B. Damico,
Sr. VP, Controller & Principal Accounting Officer -
Mike McDermott,
Chief Financial Officer -
William Pao,
Executive Vice President -
Stephen W Sanger,
Director -
Frances D Fergusson,
Director -
James C Smith,
Director -
Laurie J Olson,
Executive Vice President -
W Don Cornwell,
Director -
Loretta V Cangialosi,
Sr. Vice President, Controller -
Charles H Hill,
Executive Vice President -
Dennis A Ausiello,
Director -
Kirsten Lund Jurgensen,
Executive Vice President -
Ian C Read,
Chairman & CEO -
Freda C Lewis Hall,
Executive Vice President -
Aamir Malik,
Executive Vice President -
Christoffel Boshoff,
Executive Vice President -
Michael Goettler,
Group President -
Cyrus Taraporevala,
Director -
Iii William H Gray,
Director -
M Anthony Burns,
Director -
Cavan M. Redmond,
Group President -
Kristin C Peck,
Executive Vice President -
David S Simmons,
Business Unit President -
Geno J Germano,
Business Unit President -
Anthony J Maddaluna,
Executive Vice President -
Olivier Brandicourt,
Business Unit President -
Marc Tessier Lavigne,
Director -
George A Lorch,
Director -
Amy W Schulman,
Executive Vice President -
Constance J Horner,
Director -
Payal Sahni,
Executive Vice President -
William R Jr Carapezzi,
Executive Vice President -
Michael Mc Dermott,
Executive Vice President -
David M Denton,
Chief Financial Officer & EVP